<DOC>
	<DOCNO>NCT01572883</DOCNO>
	<brief_summary>The purpose study determine whether concomitant radiotherapy trastuzumab ( patient treat early breast cancer ) really safe heart even year treatment investigator use two treatment concomitantly without additional harm .</brief_summary>
	<brief_title>Effect Concomitant Radiotherapy Trastuzumab Cardiotoxicity Patients Treated Early Breast Cancer</brief_title>
	<detailed_description>The investigator know study , already publish , HER2 positive early breast cancer patient adjuvant treatment concomitant radiotherapy trastuzumab safe treatment . But study long term result cardial function , especially combination Left ventricular ejection fraction ( LVEF ) NT-proBNP .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Cardiotoxicity</mesh_term>
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>Early breast cancer patient , treat adjuvantly radiotherapy operate breast thoracic wall treat concomitantly trastuzumab . Reviewed many month treatment , without recurrence disease . Recurrence disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>adjuvant treatment Radiotherapy trastuzumab</keyword>
</DOC>